Creatine Supplementation for Female Football
Launched by UNIVERSITY OF SAO PAULO · Jan 31, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of creatine supplementation in female football players, particularly focusing on young and elite athletes under the age of 20. Creatine is a popular and safe dietary supplement often used to enhance athletic performance, but there is limited research on how it affects female athletes. In this study, some players will receive creatine, while others will receive a placebo (a substance with no active ingredients) to compare the results. Researchers will monitor their performance through various tests and check their health by analyzing blood and urine samples before and after the supplementation.
If you are a female football player aged 18 or older, you may be eligible to participate. Participants can expect to take creatine or a placebo for about a week and undergo performance tests, with additional check-ups throughout the football season to ensure their safety. This research aims to provide valuable insights into how creatine can impact female athletes, helping to shape future recommendations in sports nutrition. If you're interested in participating or want to learn more, please consider reaching out to the study team.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • female football players
- Exclusion Criteria:
- • age under 18
About University Of Sao Paulo
The University of São Paulo (USP) is a prestigious public research university located in Brazil, renowned for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USP leverages its extensive academic resources, interdisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking research aimed at improving patient outcomes and addressing critical health challenges. The university's strong emphasis on ethical standards and regulatory compliance ensures that all clinical trials are conducted with the highest integrity, fostering collaboration among researchers, healthcare professionals, and the broader community to enhance scientific discovery and translate findings into practical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
São Paulo, Sao Paulo / Sp, Brazil
Sao Paulo, , Brazil
São Paulo, , Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported